These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 4593596)

  • 21. Production of microbial neuraminidases induced by colominic acid.
    Uchida Y; Tsukada Y; Sugimori T
    Biochim Biophys Acta; 1974 Jun; 350(2):425-31. PubMed ID: 4847570
    [No Abstract]   [Full Text] [Related]  

  • 22. [Neuraminic acid as a cell receptor for virus of influenza].
    Tsvetkova IV; Lipkind MA; Zakstsl'skaia LIa; Iusipova NA; Rozenfel'd EL
    Biokhimiia; 1967; 32(5):994-9. PubMed ID: 5599905
    [No Abstract]   [Full Text] [Related]  

  • 23. Interferon bioassay: reduction in yield of myxovirus neuraminidases.
    Sedmak JJ; Grossberg SE
    J Gen Virol; 1973 Oct; 21():1-7. PubMed ID: 4357373
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the neuraminidases of influenza virus. 3. Stimulation of activity by bivalent cations.
    Wilson VW; Rafelson MR
    Biochim Biophys Acta; 1967 Sep; 146(1):160-6. PubMed ID: 6060460
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of neuraminidases of the same subtype but from different species using a new method of titration.
    Fiszon B; Hannoun C
    J Virol Methods; 1990 Jan; 27(1):79-90. PubMed ID: 2307719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical and chemical studies on ceruloplasmin. 8. Preparation of N-acetylneuraminic acid-1-14C-labeled ceruloplasmin.
    Hickman J; Ashwell G; Morell AG; van den Hamer CJ; Scheinberg IH
    J Biol Chem; 1970 Feb; 245(4):759-66. PubMed ID: 4313609
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pathogenetic significance of microbial neuraminidases].
    Müller HE
    Dtsch Med Wochenschr; 1974 Sep; 99(39):1933-40. PubMed ID: 4153791
    [No Abstract]   [Full Text] [Related]  

  • 28. Differences in substrate specificity of myxovirus neuraminidases.
    Drzeniek R; Gauhe A
    Biochem Biophys Res Commun; 1970 Feb; 38(4):651-6. PubMed ID: 5443707
    [No Abstract]   [Full Text] [Related]  

  • 29. [2-Deoxy-2,3-dehydrosialic acids. II. Competitive inhibition of Vibrio cholerae neuraminidase by 2-deoxy-2,3-dehydro-N-acylneuraminic acids].
    Meindl P; Tuppy H
    Hoppe Seylers Z Physiol Chem; 1969 Sep; 350(9):1088-92. PubMed ID: 5349377
    [No Abstract]   [Full Text] [Related]  

  • 30. [Orthomyxovirus neuraminidase].
    Isaeva ES; Sokolov MI
    Vopr Virusol; 1974; (5):515-21. PubMed ID: 4612999
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuraminidase action on the human urinary glycoprotein of Tamm and Horsfall.
    Pape L; Maxfield M
    Biochim Biophys Acta; 1967 Apr; 133(3):574-81. PubMed ID: 6068546
    [No Abstract]   [Full Text] [Related]  

  • 32. Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses.
    Wen WH; Wang SY; Tsai KC; Cheng YS; Yang AS; Fang JM; Wong CH
    Bioorg Med Chem; 2010 Jun; 18(11):4074-84. PubMed ID: 20452227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neuraminidases of rat eyes.
    Tulsiani DR; Nordquist RE; Carubelli R
    Exp Eye Res; 1973 Jan; 15(1):93-103. PubMed ID: 4683843
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid.
    Meindl P; Bodo G; Palese P; Schulman J; Tuppy H
    Virology; 1974 Apr; 58(2):457-63. PubMed ID: 4362431
    [No Abstract]   [Full Text] [Related]  

  • 35. Structural and functional-group tuning in the design of neuraminidase inhibitors.
    Sabesan S; Neira S; Wasserman Z
    Carbohydr Res; 1995 Feb; 267(2):239-61. PubMed ID: 7895225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of glycosphingolipid structures by mass spectrometry.
    Sweeley CC; Dawson G
    Biochem Biophys Res Commun; 1969 Sep; 37(1):6-14. PubMed ID: 5346362
    [No Abstract]   [Full Text] [Related]  

  • 37. Inability of isoquinoline derivatives to inhibit virus neuraminidase activity.
    Shinkai K; Nishimura T
    J Gen Virol; 1972 Aug; 16(2):227-9. PubMed ID: 5072367
    [No Abstract]   [Full Text] [Related]  

  • 38. Contribution to the standardization of influenza neuraminidase inhibition tests, based on enzyme- antienzyme kinetic studies.
    Siekmann U; Schoop HJ; Kuwert E
    Dev Biol Stand; 1975; 28():324-35. PubMed ID: 1126576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologic studies of the neuraminidases of Vibrio cholerae, Diplococcus pneumoniae and influenza virus.
    MADOFF MA; EYLAR EH; WEINSTEIN L
    J Immunol; 1960 Dec; 85():603-13. PubMed ID: 13765078
    [No Abstract]   [Full Text] [Related]  

  • 40. [The occurrence of neuraminidase in Mycoplasma gallisepticum].
    Müller HE; Sethi KK
    Med Microbiol Immunol; 1972; 157(2):160-8. PubMed ID: 5025772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.